Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  


Here is the latest stock price and chart of GLENMARK PHARMA. For more details, see the GLENMARK PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

One Stock Crorepati: Today is Your LAST Chance to Grab this Opportunity

Live BSE Quotes Jul 4, 2022 03:31:00 PM
Price (Rs)388.00 Open (Rs) 396.70 High (Rs) 397.00 Low (Rs) 384.10
% Change-1.52 Volume 20,403 Value (Rs) 7,916,364 52-Week H/L 690.60 / 348.90
Live NSE Quotes Jul 4, 2022 3:29:56 PM
Price (Rs)387.05 Open (Rs) 394.10 High (Rs) 397.40 Low (Rs) 384.00
% Change-1.79 Volume 516,166 Value (Rs) 200,432,419 52-Week H/L 690.95 / 348.50
1 Day
1 Month
3 Months
1 Year
5 Years (CAGR)*
10 Years (CAGR)*

* Compound Annual Growth Rate

EPS (Rs)* 35.21 P/E Ratio (x) 11.02 Market Cap (Rs m) 109,481.26 P/BV (x) 1.23 Dividend Yield (%) 0.64
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Peer Group:
Quote & Graph
Advanced Charts new
Charts by TradingView

GLENMARK PHARMA Share Price Today:

GLENMARK PHARMA last traded price was down 1.5% to Rs 388.0 on the BSE. On the NSE, GLENMARK PHARMA last traded price was down 1.8% to Rs 387.1. The total volume of shares traded was 0.5 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 0.0%. And the benchmark S&P BSE SENSEX was at 53,234.8 (up 0.6%).

Over the last 30 days, the GLENMARK PHARMA share price is down 5.3%. And over the last one year, GLENMARK PHARMA share price is down 40.6%.

The current market capitalisation of GLENMARK PHARMA stands at Rs 109,481.26 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of March 2022, company promoters held 46.65% stake in GLENMARK PHARMA, with no shares having been pledged. To know more, check out the latest shareholding pattern of GLENMARK PHARMA.

What else is happening in the markets today? Dig in...


What is the GLENMARK PHARMA share price today?

The last traded price of GLENMARK PHARMA was Rs 388.0 on the BSE, down 1.5% over the previous close. On the NSE, GLENMARK PHARMA last traded price was down 1.8% at Rs 387.1.

What is the market cap of GLENMARK PHARMA?

The current market capitalisation of GLENMARK PHARMA stands at Rs 109,481 m.

What is the Earnings per share (EPS) of GLENMARK PHARMA?

GLENMARK PHARMA had an EPS of Rs 35.2 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs 6.1.

What is the PE Ratio and PB Ratio of GLENMARK PHARMA?

At the current price of Rs 388.0, GLENMARK PHARMA trades at a PE ratio of 11.02 while its PB ratio stands at 1.23.

What is the Dividend Yield of GLENMARK PHARMA?

For the financial year 2021, GLENMARK PHARMA declared dividend amounting to Rs 2.5 per share. At the current price of Rs 388.0, this results in a dividend yield of 0.6%.

Today's Market

Sensex Ends 327 Points Higher as FMCG Stocks Rally; HUL, Britannia & ITC Top Gainers(Closing)

After opening the day on a choppy note, Indian share markets rallied as the session progressed and ended higher.

Related Views On News

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

5 Consistent Compounding Stocks Available at Discount. Time to Buy? (Views On News)

Jun 22, 2022

The good side of a market correction? Investors get consistent compounding stocks at a discount.

Wait! Don't Buy the Smallcap 'Dip' Just Yet (Profit Hunter)

Jun 20, 2022

Why this may not be the best time to buy smallcaps.

Looking for Value Stocks Amid Volatile Times? Consider These 5 Stocks (Views On News)

Jun 20, 2022

These value stocks have the potential to deliver good returns in the long run. Watch out for them.

Why Crude Oil Price is Falling (Views On News)

Jun 25, 2022

Global markets have become volatile, sending chills through the crude oil market.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks